Original articleTear Osmolarity in the Diagnosis and Management of Dry Eye Disease
Section snippets
Methods
A prospective, exploratory, multicenter study was undertaken at 10 sites in the European Union and the United States. The subject population consisted of randomly presenting subjects between the ages of 18 and 82 years of both sexes, including those with and without a history of dry eye disease. Investigators were instructed to recruit roughly a 2:1 ratio of presumed dry eye patients to normals. This report documents the results of the analysis of the initial 314 subjects, 15 of whom were
Results
Tear osmolarity was found to have a 72.8% sensitivity and 92.0% specificity at a cutoff value of 312 mOsms/L (i.e., values > 311 mOsms/L; Table 1). No other clinical sign exhibited more than 62% performance in both categories. Corneal staining, conjunctival staining, and meibomian grading lacked sensitivity (54.0%, 60.3%, and 61.2% respectively), whereas TBUT and Schirmer results lacked specificity (45.3% and 50.7%, respectively). The performance of osmolarity was consistent with earlier
Discussion
The development and availability of a new technology (TearLab; FDA 510(k) k083184) enables the clinician to collect and measure osmolarity in a 50 nL sample with minimal disturbance of the tear film.5 This microfluidic lab-on-a-chip device both collects tears and produces a reading within seconds before evaporation can influence solute concentration. This eliminates the need for sample transfer or user handling. This technique is applicable in the near-patient setting and overcomes many of the
Michael A. Lemp, a corneal specialist, is clinical professor of ophthalmology at Georgetown and George Washington universities, former chair of ophthalmology at Georgetown, and the author of 210 scientific papers and five books. He is retired from clinical practice but is active in clinical research in ocular surface disease. He is founding editor of The Ocular Surface, recipient of the Castroviejo medal, reviewer for eight journals and consultant for companies developing drugs and devices.
References (24)
- et al.
Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification and grading
Ocul Surf
(2003) - et al.
Predicted phenotypes of dry eye: proposed consequences of its natural history
Ocul Surf
(2009) - et al.
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye
Exp Eye Res
(2006) Epidemiology of dry eye disease
Methodologies to diagnose and monitor dry eye disease
Ocul Surf
(2007)- et al.
The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity
Invest Ophthalmol Vis Sci
(2003) The definition and classification of dry eye disease
Ocul Surf
(2007)- et al.
An objective approach to severity in dry eye disease
Invest Ophthalmol Vis Sci
(2010) Survey of preferred tests for the diagnosis of the tear film and dry eye
Cornea
(2000)- et al.
An information-maximization approach to blind separation and blind deconvolution
Neural Comp
(1995)
Tear film osmolarity: determination of a referent for dry eye diagnosis
Invest Ophthalmol Vis Sci
Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques
Cornea
Cited by (502)
Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation
2024, Experimental Eye ResearchDiagnosing dry-eye: Which tests are most accurate?
2023, Contact Lens and Anterior EyeDry eye clinical practice patterns of UK optometrists
2023, Contact Lens and Anterior EyeTear-film evaporation flux and its relationship to tear properties in symptomatic and asymptomatic soft-contact-lens wearers
2023, Contact Lens and Anterior EyeInternational survey on dry eye diagnosis by experts
2023, Heliyon
Michael A. Lemp, a corneal specialist, is clinical professor of ophthalmology at Georgetown and George Washington universities, former chair of ophthalmology at Georgetown, and the author of 210 scientific papers and five books. He is retired from clinical practice but is active in clinical research in ocular surface disease. He is founding editor of The Ocular Surface, recipient of the Castroviejo medal, reviewer for eight journals and consultant for companies developing drugs and devices.